Literature DB >> 31000662

Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1.

Meng He1, Mira S Chaurushiya1, Joshua D Webster2, Sarah Kummerfeld3, Rohit Reja3, Subhra Chaudhuri4, Ying-Jiun Chen4, Zora Modrusan4, Benjamin Haley4, Debra L Dugger1, Jeffrey Eastham-Anderson2, Shari Lau2, Anwesha Dey5, Roger Caothien4, Merone Roose-Girma4, Kim Newton6, Vishva M Dixit6.   

Abstract

Malignancies arising from mutation of tumor suppressors have unexplained tissue proclivity. For example, BAP1 encodes a widely expressed deubiquitinase for histone H2A, but germline mutations are predominantly associated with uveal melanomas and mesotheliomas. We show that BAP1 inactivation causes apoptosis in mouse embryonic stem cells, fibroblasts, liver, and pancreatic tissue but not in melanocytes and mesothelial cells. Ubiquitin ligase RNF2, which silences genes by monoubiquitinating H2A, promoted apoptosis in BAP1-deficient cells by suppressing expression of the prosurvival genes Bcl2 and Mcl1. In contrast, BAP1 loss in melanocytes had little impact on expression of prosurvival genes, instead inducing Mitf Thus, BAP1 appears to modulate gene expression by countering H2A ubiquitination, but its loss only promotes tumorigenesis in cells that do not engage an RNF2-dependent apoptotic program.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31000662     DOI: 10.1126/science.aav4902

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  30 in total

1.  BAP1 promotes the repair of UV-induced DNA damage via PARP1-mediated recruitment to damage sites and control of activity and stability.

Authors:  Shin-Ai Lee; Daye Lee; Minhwa Kang; Sora Kim; Su-Jung Kwon; Han-Sae Lee; Hye-Ran Seo; Prashant Kaushal; Nam Soo Lee; Hongtae Kim; Cheolju Lee; Jongbum Kwon
Journal:  Cell Death Differ       Date:  2022-05-30       Impact factor: 15.828

2.  Epigenetic targeted therapy of stabilized BAP1 in ASXL1 gain-of-function mutated leukemia.

Authors:  Lu Wang; Noah Warren Birch; Zibo Zhao; Carson Meredith Nestler; Alexander Kazmer; Anthony Shilati; Alisha Blake; Patrick Alexander Ozark; Emily Jane Rendleman; Didi Zha; Caila Ann Ryan; Marc Alard Jonathan Morgan; Ali Shilatifard
Journal:  Nat Cancer       Date:  2021-05-25

3.  BAP1 forms a trimer with HMGB1 and HDAC1 that modulates gene × environment interaction with asbestos.

Authors:  Flavia Novelli; Angela Bononi; Qian Wang; Fang Bai; Simone Patergnani; Franz Kricek; Ellinor Haglund; Joelle S Suarez; Mika Tanji; Ronghui Xu; Yasutaka Takanishi; Michael Minaai; Sandra Pastorino; Paul Morris; Greg Sakamoto; Harvey I Pass; Haithem Barbour; Giovanni Gaudino; Carlotta Giorgi; Paolo Pinton; Jose N Onuchic; Haining Yang; Michele Carbone
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-30       Impact factor: 11.205

4.  BAP1 maintains HIF-dependent interferon beta induction to suppress tumor growth in clear cell renal cell carcinoma.

Authors:  Lauren E Langbein; Rayan El Hajjar; Shen He; Eleonora Sementino; Zhijiu Zhong; Wei Jiang; Benjamin E Leiby; Li Li; Robert G Uzzo; Joseph R Testa; Haifeng Yang
Journal:  Cancer Lett       Date:  2022-08-20       Impact factor: 9.756

Review 5.  Deubiquitinases in cell death and inflammation.

Authors:  Kim Newton; Alexander D Gitlin
Journal:  Biochem J       Date:  2022-05-27       Impact factor: 3.766

Review 6.  Saga of Mcl-1: regulation from transcription to degradation.

Authors:  Viacheslav V Senichkin; Alena Y Streletskaia; Anna S Gorbunova; Boris Zhivotovsky; Gelina S Kopeina
Journal:  Cell Death Differ       Date:  2020-01-06       Impact factor: 15.828

Review 7.  Ubiquitin-proteasome system-targeted therapy for uveal melanoma: what is the evidence?

Authors:  Chen-Xi Zhao; Chen-Ming Zeng; Ke Wang; Qiao-Jun He; Bo Yang; Fan-Fan Zhou; Hong Zhu
Journal:  Acta Pharmacol Sin       Date:  2020-06-29       Impact factor: 6.150

Review 8.  Roles and mechanisms of BAP1 deubiquitinase in tumor suppression.

Authors:  Louis Masclef; Oumaima Ahmed; Benjamin Estavoyer; Bruno Larrivée; Nathalie Labrecque; Anastasia Nijnik; El Bachir Affar
Journal:  Cell Death Differ       Date:  2021-01-18       Impact factor: 12.067

9.  BAP1/ASXL complex modulation regulates epithelial-mesenchymal transition during trophoblast differentiation and invasion.

Authors:  Vicente Perez-Garcia; Georgia Lea; Pablo Lopez-Jimenez; Hanneke Okkenhaug; Graham J Burton; Ashley Moffett; Margherita Y Turco; Myriam Hemberger
Journal:  Elife       Date:  2021-06-25       Impact factor: 8.140

10.  Gain-of-Function Genetic Alterations of G9a Drive Oncogenesis.

Authors:  Shinichiro Kato; Qing Yu Weng; Megan L Insco; Kevin Y Chen; Sathya Muralidhar; Joanna Pozniak; Joey Mark S Diaz; Yotam Drier; Nhu Nguyen; Jennifer A Lo; Ellen van Rooijen; Lajos V Kemeny; Yao Zhan; Yang Feng; Whitney Silkworth; C Thomas Powell; Brian B Liau; Yan Xiong; Jian Jin; Julia Newton-Bishop; Leonard I Zon; Bradley E Bernstein; David E Fisher
Journal:  Cancer Discov       Date:  2020-04-08       Impact factor: 38.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.